Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stuart Kaplan

Neurological Surgery Las Vegas, NV Medical Doctor

NPI 1508823824 CMS profile 804517

3012 S Durango Dr, Las Vegas, NV 89117

Open in the dashboard

General payments

$6,847

219 records reported · program years 2019–2025

Research payments

$22,200

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stuart Kaplan of Las Vegas, NV is reported in the CMS Open Payments database as having received $6,847 across 219 general payments and $22,200 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $832 34
2024 General $890 33
2023 General $387 21
2022 General $2,770 24
2021 General $415 24
2020 General $427 20
2020 Research $3,900 1
2019 General $1,126 63
2019 Research $18,300 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stuart Kaplan
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Stuart Kaplan were reported at $832. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Stuart Kaplan Neurological Surgery median Middle half National median
2019 $1,126 $582 $138–$3,006 $163
2020 $427 $294 $76–$2,174 $114
2021 $415 $387 $105–$2,432 $132
2022 $2,770 $542 $139–$2,989 $149
2023 $387 $534 $145–$2,697 $160
2024 $890 $574 $155–$3,046 $164
2025 $832 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CoreLink, LLC $2,141 9 payments
  2. Abbott Laboratories $1,260 58 payments
  3. Medtronic USA, Inc. $596 47 payments
  4. Providence Medical Technology, Inc. $480 28 payments
  5. Boston Scientific Corporation $328 10 payments
  6. Stryker Corporation $275 6 payments
  7. NuVasive, Inc. $268 12 payments
  8. Medtronic, Inc. $259 9 payments
  9. Nevro Corp. $229 7 payments
  10. Saluda Medical Americas, Inc. $137 1 payment
  11. Other $875 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,698 211 payments
  2. Travel and Lodging $1,719 6 payments
  3. Entertainment $390 1 payment
  4. Education $40 1 payment
Products named General payments · program years 2019–2025
  1. PENTA $329 11 payments
  2. Senza $211 6 payments
  3. KYPHON Balloon Kyphoplasty $197 17 payments
  4. PROCLAIM Neuromodulation $193 12 payments
  5. MYSTIM $161 11 payments
  6. Clinical Trial Product $159 1 payment
  7. PROCLAIM Structural Heart $157 9 payments
  8. Evoke $137 1 payment
  9. Penta SCS Leads $134 5 payments
  10. PROCLAIM Neuromodulation $121 7 payments
  11. Other $2,464 106 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. RTI Surgical, Inc. $22,200 2 payments

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$73,575

Medicare's payments for the services billed

Medicare patients

191

Average age 72

Services billed

424

109 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 42%
Ischemic heart disease 38%
Depression 36%
Chronic kidney disease 28%
COPD 24%
Heart failure 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

221 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record